LCTX Earnings Lineage Cell Therapeutics, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–42 of 42
| Q2 2026 | 2026-06-30 | -0.06 | 2026-08-06 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.03 | 2026-05-12 | 10-Q |
| FY 2025 | 2025-12-31 | -0.28 | 2026-03-05 | 10-K |
| Q3 2025 | 2025-09-30 | -0.28 | 2025-11-06 | 10-Q |
| Q2 2026 | 2025-06-30 | -0.15 | 2026-08-06 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.02 | 2026-05-12 | 10-Q |
| FY 2025 | 2024-12-31 | -0.09 | 2026-03-05 | 10-K |
| Q3 2025 | 2024-09-30 | -0.08 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.07 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.04 | 2025-05-13 | 10-Q |
| FY 2024 | 2023-12-31 | -0.12 | 2025-03-10 | 10-K |
| Q3 2024 | 2023-09-30 | -0.10 | 2024-11-14 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.06 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.03 | 2024-05-09 | 10-Q |
| FY 2023 | 2022-12-31 | -0.15 | 2024-03-07 | 10-K |
| FY 2023 | 2022-09-30 | -0.04 | 2024-03-07 | 10-K |
| FY 2023 | 2022-06-30 | -0.04 | 2024-03-07 | 10-K |
| FY 2023 | 2022-03-31 | -0.04 | 2024-03-07 | 10-K |
| Q3 2022 | 2021-09-30 | -0.09 | 2022-11-10 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.04 | 2022-08-11 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.01 | 2022-05-12 | 10-Q |
| Q3 2021 | 2020-09-30 | -0.15 | 2021-11-10 | 10-Q |
| Q2 2021 | 2020-06-30 | -0.10 | 2021-08-12 | 10-Q |
| Q1 2021 | 2020-03-31 | -0.06 | 2021-05-13 | 10-Q |
| Q3 2020 | 2019-09-30 | -0.05 | 2020-11-04 | 10-Q |
| Q2 2020 | 2019-06-30 | 0.07 | 2020-08-06 | 10-Q |
| Q1 2020 | 2019-03-31 | 0.30 | 2020-05-07 | 10-Q |
| Q3 2019 | 2018-09-30 | -0.01 | 2019-11-12 | 10-Q |
| Q2 2019 | 2018-06-30 | -0.53 | 2019-08-08 | 10-Q |
| Q1 2019 | 2018-03-31 | -0.50 | 2019-05-09 | 10-Q |
| FY 2017 | 2017-12-31 | -0.17 | 2018-03-15 | 10-K |
| Q3 2018 | 2017-09-30 | 0.47 | 2018-11-08 | 10-Q |
| Q2 2018 | 2017-06-30 | 0.34 | 2018-08-02 | 10-Q |
| Q1 2018 | 2017-03-31 | 0.46 | 2018-05-10 | 10-Q |
| FY 2017 | 2016-12-31 | 0.34 | 2018-03-15 | 10-K |
| Q3 2017 | 2016-09-30 | 0.39 | 2017-11-09 | 10-Q |
| Q2 2017 | 2016-06-30 | 0.08 | 2017-08-09 | 10-Q |
| Q1 2017 | 2016-03-31 | -0.19 | 2017-05-10 | 10-Q |
| FY 2017 | 2015-12-31 | -0.59 | 2018-03-15 | 10-K |
| Q3 2016 | 2015-09-30 | -0.43 | 2016-11-04 | 10-Q |
| Q2 2016 | 2015-06-30 | -0.25 | 2016-08-09 | 10-Q |
| FY 2016 | 2014-12-31 | -0.55 | 2017-03-16 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.